Integrated Two-Analyte Population Pharmacokinetic Model of Polatuzumab Vedotin in Patients With Non-Hodgkin Lymphoma. - Lu D; Lu T; Gibiansky L; Li X; Li C; Agarwal P; Shemesh CS; Shi R; Dere RC; Hirata J; Miles D; Chanu P; et al. (CPT: pharmacometrics & systems pharmacology, 2020)